Ambeed.cn

首页 / / / 组蛋白乙酰转移酶 / C646

C646 {[allProObj[0].p_purity_real_show]}

货号:A122218

C646 是一种选择性竞争性的乙酰化酶histone acetyltransferase p300 抑制剂,Ki 值为 400 nM,对其他乙酰转移酶的作用较小。

C646 化学结构 CAS号:328968-36-1
C646 化学结构
CAS号:328968-36-1
C646 3D分子结构
CAS号:328968-36-1
C646 化学结构 CAS号:328968-36-1
C646 3D分子结构 CAS号:328968-36-1
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

C646 纯度/质量文件 产品仅供科研

货号:A122218 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

C646 生物活性

靶点
  • p300/CBP

    p300/CBP, Ki:400 nM

描述 The histone acetyltransferase p300/CBP is a transcriptional coactivator involved in many regulatory pathways during tumorigenesis. C646 is a selective and competitive p300 inhibitor with a Ki value of 400nM. Treatment of C3H 10T1/2 mouse fibroblasts with C646 (25μM) resulted in a reduction in the levels of histone H3 and H4 acetylation. C646 at a concentration of 25μM also inhibited TSA-induced acetylation in mouse fibroblasts. C646 at 10μM was capable of reducing 3H-thymidine incorporation in several human cancer cell lines. The IC50 value of C646 for the growth of melanoma cell line WM983A was 10-20μM[3] The suppression of P300 by C646 via intraperitoneal injection (30nmol/g/day for two weeks) reduced the level of blood glucose, rescued impaired autophagic flux, and resulted in an 18.5% increase in muscle mass in db/db mice.[4]
作用机制 C646 is a competitive, highly selective inhibitor of p300 versus other acetyltransferases.[3]

C646 细胞实验

Cell Line
Concentration Treated Time Description References
Porcine aortic valve interstitial cells (pAVICs) 10 μM 3 days C646 treatment significantly reduced calcium deposition, decreased ALP activity, and reduced the expression of osteogenic marker genes, indicating that C646 can attenuate high-calcium/high-phosphate-induced calcification. Exp Mol Med. 2019 Jul 10;51(7):1-14.
Adult mouse primary cardiac fibroblasts (ACFs) 3 μM 24 h Inhibit the acetyltransferase activity of P300 and observe the effect of C646 on fibroblast activation. Results showed that C646 pretreatment reversed CAR3 deficiency-induced suppression of fibroblast activation and improved cardiac healing and collagen synthesis. Int J Biol Sci. 2024 Feb 25;20(5):1796-1814.
Drosophila S2 cells 30 μM 10 min CBP inhibition resulted in down-regulation of 3790 genes, indicating the critical role of CBP in transcription regulation Mol Cell. 2017 Nov 2;68(3):491-503.e5.
HCT116 colon cancer cells 10 µM 12 and 96 h To assess the effects of C646 on the transcriptome of HCT116 cells, it was found that C646 downregulated genes related to the WNT signaling pathway. Epigenetics Chromatin. 2015 Feb 24;8:9.
PANC1 pancreatic cancer cells 10 µM 12 and 96 h To assess the effects of C646 on the transcriptome of PANC1 cells, it was found that C646 downregulated cell cycle-related genes but did not significantly affect the WNT signaling pathway. Epigenetics Chromatin. 2015 Feb 24;8:9.
SK-BR-3 8 μM 72 h C646 prevented PEPD KD from causing K373 acetylation of p53 mutants and induction of p53 target proteins, despite profound PEPD KD. Commun Biol. 2021 Dec 8;4(1):1373.
MDA-MB-231 8 μM 72 h C646 prevented PEPD KD from causing K373 acetylation of p53 mutants and induction of p53 target proteins, despite profound PEPD KD. Commun Biol. 2021 Dec 8;4(1):1373.

C646 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 male mice Colon cancer transplantation tumor model Intraperitoneal injection 30 nmol/g Every 3 days for 2 weeks C646 significantly inhibited the growth of CXCL1-overexpressing colon cancer tumors. Biol Direct. 2022 Nov 25;17(1):34
Mice MCA205 fibrosarcoma model Intraperitoneal injection 10 mg/kg Daily, throughout the treatment To evaluate the antitumor effects of C646 in vivo, results showed that C646 could enhance the antitumor effects of chemotherapy by inducing autophagy. Cancer Cell. 2016 Jul 11;30(1):147-160
Mice Adenine and vitamin D-induced aortic valve calcification model Subcutaneous injection 1 mg/kg Once daily for 14 days C646 treatment significantly attenuated aortic valve calcification and restored the levels of acetylated histones 3 and 4, indicating that C646 has an inhibitory effect on calcification in vivo. Exp Mol Med. 2019 Jul 10;51(7):1-14.
Mice Myocardial infarction model Intraperitoneal injection 15 mg/kg Once daily for 14 consecutive days Inhibit the acetyltransferase activity of p300 and observe the effect of C646 on cardiac healing and function. Results showed that C646 pretreatment reversed CAR3 deficiency-induced impairment of cardiac healing and function, and improved collagen synthesis. Int J Biol Sci. 2024 Feb 25;20(5):1796-1814.
Mice TC1 and AE17 tumor models Subcutaneous injection 8.9 mg/kg Once daily for 3 days To evaluate the effect of p300i on tumor growth, results showed that p300i significantly inhibited tumor growth. Nat Med. 2013 Sep;19(9):1173-7.

C646 动物研究

Dose Mice: 1 mg/kg[3] (nasal injection), 1 mg/kg[4] (s.c.), 25 mg/kg[5] (i.p.)
Administration Nasal injection, s.c., i.p.

C646 参考文献

[1]Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, Crump NT, Hazzalin CA, Liszczak G, Yuan H, Larocca C, Saldanha SA, Abagyan R, Sun Y, Meyers DJ, Marmorstein R, Mahadevan LC, Alani RM, Cole PA. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol. 2010 May 28;17(5):471-82

[2]Fan Z, Wu J, Chen QN, Lyu AK, Chen JL, Sun Y, Lyu Q, Zhao YX, Guo A, Liao ZY, Yang YF, Zhu SY, Jiang XS, Chen B, Xiao Q. Type 2 diabetes-induced overactivation of P300 contributes to skeletal muscle atrophy by inhibiting autophagic flux. Life Sci. 2020 Oct 1;258:118243

C646 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.25mL

0.45mL

0.22mL

11.23mL

2.25mL

1.12mL

22.45mL

4.49mL

2.25mL

C646 技术信息

CAS号328968-36-1
分子式C24H19N3O6
分子量 445.42
SMILES Code O=C(O)C1=CC=C(N2N=C(C)/C(C2=O)=C/C3=CC=C(C4=CC(C)=C(C)C=C4[N+]([O-])=O)O3)C=C1
MDL No. MFCD01784780
别名
运输蓝冰
InChI Key HEKJYZZSCQBJGB-UNOMPAQXSA-N
Pubchem ID 1285941
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 12 mg/mL(26.94 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。